Press releases and News

2022-07-01 18:00 Regulatory
NOT FOR PUBLICATION, DISTRIBUTION OR RELEASE, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO AUSTRALIA, CANADA, HONG KONG, JAPAN, NEW ZEALAND, SINGAPORE, SOUTH AFRICA, SWITZERLAND, UNITED STATES OF AMERICA OR ANY OTHER JURISDICTION IN WHICH THE...
2022-06-27 11:30 Regulatory
The extraordinary general meeting in Senzime AB (publ), corp. reg. no 556565-5734 (the “Company”) was held on 27 June 2022 by voting in advance, whereby the shareholders primarily resolved on the following matter. Authorization to the board...
2022-06-21 08:30 Regulatory
Press release: Uppsala, June 21, 2022. Senzime today announces that they have signed a license and connectivity agreement with Masimo, a US-headquartered and global leader in patient monitoring solutions. With the agreement a new dedicated module is to...
2022-06-16 21:30 Regulatory
Correction – The record date for the general meeting should be June 16, 2022. The postal vote shall be received by the Company no later than June 23, 2022. Voting registration requested in such time that the registration has been completed by the...
2022-06-02 09:20
Senzime AB (publ), announced on June 1 that the company has entered into an agreement to acquire the US company Respiratory Motion. Following this announcement, Senzime invites investors, analysts, and media to an webcast (in English) with a Q&A-session...
2022-06-01 21:45 Regulatory
Senzime AB (publ) (”Senzime” or the ”Company”) has completed a directed share issue of 5,263,158 shares at a subscription price of SEK 19 per share (the “Directed Issue”), through which the Company receives approximately...
2022-06-01 17:32 Regulatory
The shareholders in Senzime AB (publ) corp. reg. no 556565-5734 (the “Company”) are hereby convened to an extraordinary general meeting on Monday June 27, 2022. The board of directors has decided in accordance with the Swedish Act on Temporary...
2022-06-01 17:31 Regulatory
Senzime AB (publ) (”Senzime” or the ”Company”) intends to carry out a new issue of shares in an amount of approximately SEK 100 million directed to Swedish and international institutional investors (the “Directed Issue”)...
2022-06-01 17:30 Regulatory
Senzime AB (publ) (”Senzime” or the ”Company”) has today signed an agreement to acquire 100 percent of the shares in the US company Respiratory Motion, Inc. (“Respiratory Motion”) for an initial consideration of USD...
2022-05-19 15:15 Regulatory
Press release: Uppsala, May 19, 2022. Senzime today announces that the company is in final negotiations regarding a strategic licensing and development agreement with a market leading global player in patient monitoring. The agreement is expected to be...

Learn more

Do you want to know more?

Contact us for more information.